Search results
Showing 631 to 645 of 1364 results for social care
Agenda and papers of the NICE public board meeting on 25 September 2024
Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.
The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.
health inequalities Supporting the health and care system to implement virtual wards Social care General practice - keep...
We estimate the costs or savings (resource impact) associated with technologies and guidelines so you can plan for and implement guidance.
Evidence-based recommendations on pegunigalsidase alfa (Elfabrio) for Fabry disease (also known as alpha-galactosidase deficiency) in adults.
guidance"}}]} NICE guidance implementation toolkits To support health and care organisations in putting evidence-based recommendations...
International collaboration with NICE
Maralixibat for treating cholestatic pruritus in Alagille syndrome [ID3941]
In development Reference number: GID-TA10832 Expected publication date: TBC
In development Reference number: GID-TA11023 Expected publication date: TBC
Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTG676)
Early value assessment (EVA) guidance on digitally enabled therapies for adults with anxiety disorders.
Membership details, terms of reference and future meeting dates for our quality standards advisory committee.
Membership details, terms of reference and future meeting dates for our quality standards advisory committee.
Onasemnogene abeparvovec for treating spinal muscular atrophy (HST15)
Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating spinal muscular atrophy in babies.
This guide provides an overview of the principles and methods of health technology assessment and appraisal within the context of the NICE appraisal process